ARS Pharmaceuticals Financial Overview
ARS Pharmaceuticals's market cap is currently $1.12B. The company's EPS TTM is $-0.52; its P/E ratio is -14.04; ARS Pharmaceuticals is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
